Finn RS, Ikeda M, Zhu AX, Sung MW, et al. Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma. J Clin Oncol 2020 Jul 27:JCO2000808. doi: 10.1200/JCO.20.00808.
PMID: 32716739